ArticleScientific reports2026
Epidemiology and risk factors of urolithiasis in the Turkestan region: a case-control study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to identify epidemiological factors associated with Urolithiasis (UL) in the Turkestan region of the Republic of Kazakhstan to inform targeted prevention strategies. The study was conducted in 2023–2024 at three major medical institutions in the region and included 1,660 participants: 410 patients with UL and 1,250 controls without a history of the disease. Data collection involved patient questionnaires, medical record analysis, laboratory and instrumental diagnostics, and assessment of drinking water quality. Detailed laboratory and instrumental examinations were performed in 298 patients and 301 controls who provided informed consent. The UL recurrence rate was 40%. Patients had a longer average duration of residence in the region than controls (20.6 vs. 16.4 years, p < 0.05), and diagnoses were more frequent in summer. UL patients showed significantly higher urinary oxalate excretion, elevated parathyroid hormone levels, and lower urine pH (all p < 0.001). Preventive measures reduced oxalate levels by 20% and increased urine pH. Regional water hardness was above average and associated with higher recurrence rates. Oxalate stones predominated. The findings highlight the role of environmental and metabolic factors and support strengthening prevention programs, including hydration, dietary modification, water quality monitoring, and early detection of hyperparathyroidism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.